Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

BACKGROUND AND AIMS: Locoregional therapies, including yttrium‐90 radioembolization, play an important role in the treatment of unresectable HCC. The aim of the LEGACY (Local radioEmbolization using Glass Microspheres for the Assessment of Tumor Control with Y‐90) study was to evaluate objective res...

Descripción completa

Detalles Bibliográficos
Autores principales: Salem, Riad, Johnson, Guy E., Kim, Edward, Riaz, Ahsun, Bishay, Vivian, Boucher, Eveline, Fowers, Kirk, Lewandowski, Robert, Padia, Siddharth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596669/
https://www.ncbi.nlm.nih.gov/pubmed/33739462
http://dx.doi.org/10.1002/hep.31819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596669/
https://www.ncbi.nlm.nih.gov/pubmed/33739462
http://dx.doi.org/10.1002/hep.31819

Ejemplares similares